Expected shortfall is hard to back-test, critics say – but the search for a solution is underway
Some banks worry they may not have enough data to implement expected shortfall safely
While the December proposals incorporate many of the industry's comments, banks claim the rules are still too harsh
Proposals on proposals
Living la vida local
Completing the two studies on schedule will be "nigh-on impossible" bankers claim – but regulators are thought to be wary of a postponement
Inflation derivatives house of the year: Barclays
Credit derivatives house of the year: Credit Suisse
The banking rulebook is becoming increasingly complex, so regulators need good quants to design and explain it - but they must also tackle the big questions of the crisis
Including funding costs and benefits in derivatives prices is a controversial topic, closely tied up with the credit and debit valuation adjustments of counterparty risk. But new research suggests that, even with no default risk, differences in the levels...
Banks turn to lawyers for advice as CVA functions face tougher conditions than other trading desks
The funding valuation adjustment (FVA) is the biggest controversy of recent times in quantitative finance. Now the authors of the original FVA paper are back – and think there may be a solution. Laurie Carver introduces this month’s technical articles
In the Basel III world, traders know their business must deliver a target return on equity, or risk being shut down – but working out the capital cost, or benefit, of a trade at inception is so difficult that banks only have approximations to guide...
French life insurers have to pay back their customers at the drop of a hat – an exposure that rises in tandem with interest rates, as customers seek better returns elsewhere. But with the industry’s traditional hedge for this risk now too pricey,...
Credit factor models tend to obscure the economics in favour of tractability – and this puts them at odds with rigorous arbitrage-free martingale pricing methods. To resolve this, quants are looking more closely at what a systematic risk factor actually...
Banks relieved as revised trading book proposals drop plans for capital to be based on regulator-set correlations
Critics of Basel III’s credit valuation adjustment (CVA) capital charge have long warned it would produce perverse incentives. Now, in the form of a string of quarterly losses in Deutsche Bank’s CVA hedging programme, they believe they are being proved...
Big loss was accompanied by even bigger capital saving, traders point out. Other banks now working out their own policy on controversial capital charge
Pricing the CVA doom loop
New research sheds light on implications of product's role as regulatory capital hedge
Arch-critic of funding valuation adjustment says regulation will make it obsolete – reducing industry's exposure to arbitrage
Academics who ignited fierce debate on funding valuation adjustment return with new paper
The CCP price